Health Jun 30 Pediatric cancer survivors face lifetime of health challenges Thanks to better treatments, more people are surviving cancer. But those treatments come with a downside: Survivors, especially those who got sick as children, are at greater risk for other significant health issues later. The NewsHour's Cat Wise profiles a…
Nation Jun 30 Supreme Court limits health care law's contraception mandate The Supreme Court ruled that family-owned corporations with religious objections are not required to pay for the contraceptive coverage of employees or their dependents. Marcia Coyle of The National Law Journal offers background on the case and Judy Woodruff gets…
World Jun 30 News Wrap: Sunni extremists declare new Islamic state in Iraq and Syria In our news wrap Monday, there was celebration and and condemnation for the announcement of a new Islamic state, or caliphate, in Iraq and Syria, declared by ISIL on Sunday. Also, President Obama formally announced his nominee to replace former…
Episode Jun 29 Sunday, June 29, 2014 On Sunday’s program, President Barack Obama will seek more than $2 billion to respond to the recent surge in illegal immigration. Later, we look at how rap music is playing an increasingly prominent role in criminal cases across the country.
Nation Jun 29 Administration will try Benghazi attack suspect in D.C. The suspect in the 2012 attack in Benghazi, Libya, appeared in U.S. District Court on Saturday in the nation’s capitol. Yesterday, the suspect, Ahmed Abu Khatallah, plead not guilty. Representative Mike Rogers said Khatallah is being “compliant, but not cooperative”…
Health Jun 29 Hospitals turning to data brokers for patient information A new report this week describes how hospitals are buying information from data brokers to determine how likely you are to get sick and what it may cost to treat you. For more on this Shannon Pettypiece of Bloomberg News…
Episode Jun 28 Saturday, June 28, 2014 On tonight’s program, the suspect in the Benghazi embassy attack is brought to the United States. Later, we investigate whether brand name drug companies are paying to keep lower-cost generic drugs off the market. And, a look at art once…